Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 4 1Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Dupuytren Contracture 4Contracture 1

Interventions

Cisplatin 187Carboplatin 182Paclitaxel 177Docetaxel 145Cyclophosphamide 129Dexamethasone 117pembrolizumab 106Doxorubicin 103Bevacizumab 103Gemcitabine 102Rituximab 96Prednisone 87Fluorouracil 86Pemetrexed 82Radiotherapy 77Vincristine 71Etoposide 71Capecitabine 69Nivolumab 68Trastuzumab 67Leucovorin 64Cytarabine 57Methotrexate 52Oxaliplatin 49atezolizumab 48Lenalidomide 43Ipilimumab 40Filgrastim 40Bortezomib 39Sorafenib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Has results × xiapex × Clear all
NCT01407068 2017-10-05

Administration of Two Injections for Multiple Dupuytren's Contractures

Endo Pharmaceuticals

Phase 3 Completed
60 enrolled 12 charts

Dupuytren Contracture

NCT01674634 2017-10-05

Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures

Endo Pharmaceuticals

Phase 3 Completed
715 enrolled 17 charts

Contracture, Dupuytren Contracture

NCT01588353 2017-03-21

CORD-J

Asahi Kasei Therapeutics Corporation

Phase 3 Completed
104 enrolled 13 charts

Dupuytren Contracture

NCT01229436 2014-03-17

POINT X

Pfizer

Phase 3 Completed
254 enrolled 28 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡